Crossmark

Improved false-negative rates using a novel patient selection flowchart in initially biopsy-proven node-positive breast cancer undergoing blue-dye alone guided sentinel lymph node biopsy after neoadjuvant chemotherapy

Crossref DOI link: https://doi.org/10.1007/s10549-022-06707-z

Published Online: 2022-09-13

Published Print: 2022-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Minyan

Li, Shengmei

Huang, Meng

Guo, Jingjing

Huang, Xuan

Guo, Wenhui

Chen, Lili

Lin, Yuxiang

Jacobs, Lisa

Wang, Chuan

Fu, Fangmeng https://orcid.org/0000-0002-3065-5708
License Information

Text and Data Mining valid from 2022-09-13

Version of Record valid from 2022-09-13
More Information

Article History

Received: 16 March 2022

Accepted: 2 August 2022

First Online: 13 September 2022

Declarations

:

: All authors declare that they have no conflict of interest.

: The study was approved by Ethics Committee, and all the participating patients signed an informed consent.

: Informed consent was obtained from all individual participants included in the study.

: The authors affirm that human research participants provided informed consent for publication of the images in Figs. (A) and 1(B).

Document is current

Any future updates will be listed below